Identification of F5 as a Prognostic Biomarker in Patients with Gastric Cancer

Figure 3

Prognostic value of F5 in patients’ dataset from TCGA cohort (). (a) F5 gene distribution; (b) patient overall survival status and survival time. The dotted line divides the patients into low-expression and high-expression groups based on median gene expression. (c) Gene expression heat map of the F5 expression profiles. Rows represent the F5 gene, and columns represent patients. As the gene expression of F5 rose, the death number of the high-expression group increased, while the OS decreased. (d) Receiver operating characteristic curve was used to predict overall survival in gastric cancer patients based on F5 expression level. TCGA: The Cancer Genome Atlas; F5: Coagulation factor V.

(a)

(b)

(c)

(d)